SCHEMBL3095218

SCHEMBL3095218

CC(C)(C)CNC(=O)c1csc(C(N)=O)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.39
NR1I2 O75469 1/20 0.38
AHR P35869 1/20 0.38
HIF1A Q16665 1/20 0.37
MAPKAPK2 P49137 1/20 0.37
ENPP2 Q13822 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3095225 0.82 MAPT (0.48) ADORA2AHIF1AMAPKAPK2ALDH1A1MAPT
SCHEMBL17761019 0.79 CFTR (0.40) CYP2C19TSHRPLA2G4A
SCHEMBL2990831 0.78 NR1I2 (0.52) NR1I2AHRENPP2MAPTHDAC1
SCHEMBL24419642 0.78 CYP1A2 (0.43) ADORA2AHIF1AMAPKAPK2ENPP2ALDH1A1
SCHEMBL2996971 0.77 USP2 (0.46) HIF1AMAPKAPK2ALDH1A1MAPTHTT
SCHEMBL2986992 0.77 PANK3 (0.54) ADORA2ANR1I2AHRHIF1AALDH1A1
SCHEMBL23193124 0.77 TLR7 (0.52) ADORA2AHIF1AMAPKAPK2HDAC3HDAC4
SCHEMBL3004442 0.76 ALOX15 (0.48) HIF1AMAPKAPK2ALDH1A1MAPTHTT
SCHEMBL17711308 0.73 PLA2G4A (0.43) HIF1AALDH1A1POLBPLA2G4A
SCHEMBL10272754 0.73 HPGD (0.66) MAPTHDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790712-B2 Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors BOEHRINGER INGELHEIM PHARMACEUTICAL, INC. (US) 2010-09-07 US disclosed
US-20060276453-A1 Anti-Cytokine Heterocyclic Compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276453-A1 Anti-Cytokine Heterocyclic Compounds MAPKAPK2, MAP4K2, MAP3K2 ADORA2A 3015/4885NR1I2 3554/4885AHR 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.